IQVIA Holdings Investor Presentation — October 2019

Document content

Copyright © 2019 IQVIA. All rights reserved.

October 30, 2019Q3 2019 Earnings Call1

This presentation should be viewed in conjunction with IQVIA’s Q3 2019 earnings callLegal

Safe Harbor Statement forForward -Looking Statements

This presentation contains “forward -lookingstatements” within themeaning ofthefederal securities laws, including Section 27AoftheSecurities Actof1933 ,asamended, andSection 21EoftheSecurities Exchange Actof1934 ,as

amended, including, without limitation, ourfull-year andfourth quarter 2019 guidance .Inthiscontext, forward -looking statements often address expected future business andfinancial performance andfinancial condition, andoften contain

words such as“expect,” “anticipate,” “intend,” “plan,”“believe,” “seek,”“see,”“will,”“would,” “target,” similar expressions, andvariations ornegatives ofthese words .Actual results may differ materially from ourexpectations duetoa

number offactors, including, butnotlimited to,thefollowing :most ofourcontracts may beterminated onshort notice, andwemay lose orexperience delays withlarge client contracts orbeunable toenter intonew contracts ;imposition of

restrictions onouruseofdata bydata suppliers ortheir refusal tolicense data tous;anyfailure byustocomply withcontractual, regulatory orethical requirements under ourcontracts, including current orchanges todata protection and

privacy laws;breaches ormisuse ofourorouroutsourcing partners’ security orcommunications systems ;hardware andsoftware failures, delays intheoperation ofourcomputer andcommunications systems orthefailure toimplement

system enhancements ;failure tomeet ourproductivity orbusiness transformation objectives ;failure tosuccessfully invest ingrowth opportunities ;ourability toprotect ourintellectual property rights andoursusceptibility toclaims byothers

thatweareinfringing ontheir intellectual property rights ;theexpiration orinability toacquire third party licenses fortechnology orintellectual property ;anyfailure byustoaccurately andtimely price andformulate cost estimates for

contracts, ortodocument change orders ;therateatwhich ourbacklog converts torevenue ;ourability toacquire, develop andimplement technology necessary forourbusiness ;consolidation intheindustries inwhich ourclients operate ;

risks related toclient ortherapeutic concentration ;therisks associated with operating onaglobal basis, including currency orexchange rate fluctuations andlegal compliance, including anti-corruption laws;risks related tochanges in

accounting standards ;general economic conditions inthemarkets inwhich weoperate, including financial market conditions andrisks related tosales togovernment entities ;theimpact ofchanges intaxlaws andregulations ;andour

ability tosuccessfully integrate, andachieve expected benefits from, ouracquired businesses .Forafurther discussion oftherisks relating tothecombined company’s business, seethe“RiskFactors” inourannual report onForm 10-Kfor